Trident Seafoods is pushing to sell its Pacific whiting processing plant in Newport, Oregon and the nearby meal plant to Pacific Seafood Group as the Pacific whiting season start quickly approaches May 15.
Trident publicly announced its plans to sell on May 10, stating it has “selected Pacific Seafood Group as the preferred buyer”, in a release.
However, the deal remains hung up on antitrust concerns, an issue that plagued Pacific during its multi-year attempt to acquire Westport, Washington-based processor Ocean Gold Seafoods.
Pacific is “willing and able to buy and operate the plant by May 15 and save the 147 jobs, if the (Oregon Department of Justice) provides assurance that the state will not object,” Pacific said in a statement, reaffirming hopes to support the Newport community it expressed in February.
If the ODOJ doesn’t give its blessing to the deal, waiting in the wings is Northwest Marine Products, a company founded in June of last year by Pacific whiting veteran Richard Carroll, who worked for Ocean Gold Seafoods for eight years until April of 2013.
According to Pacific, “If ODOJ takes eight weeks to review the proposed purchase, the plant will close.”
Full Content: Under Current News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan